KalVista Pharmaceuticals (KALV) Leases (2019 - 2024)
Historic Leases for KalVista Pharmaceuticals (KALV) over the last 5 years, with Q4 2024 value amounting to $5.6 million.
- KalVista Pharmaceuticals' Leases changed N/A to $5.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $6.9 million for FY2024, which is N/A changed from last year.
- Per KalVista Pharmaceuticals' latest filing, its Leases stood at $5.6 million for Q4 2024.
- KalVista Pharmaceuticals' 5-year Leases high stood at $7.6 million for Q3 2023, and its period low was $1.3 million during Q4 2020.
- Its 4-year average for Leases is $4.5 million, with a median of $5.7 million in 2024.
- In the last 5 years, KalVista Pharmaceuticals' Leases surged by 21920.79% in 2020 and then plummeted by 2261.26% in 2024.
- KalVista Pharmaceuticals' Leases (Quarter) stood at $1.3 million in 2020, then grew by 26.67% to $1.7 million in 2021, then skyrocketed by 341.5% to $7.3 million in 2023, then dropped by 23.62% to $5.6 million in 2024.
- Its Leases stands at $5.6 million for Q4 2024, versus $5.9 million for Q4 2024 and $5.9 million for Q3 2024.